查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950527

周邊血管血管造影術導管市場按產品類型、材料、最終用戶和應用分類－全球預測，2026-2032年

Peripheral Vascular Angiography Catheter Market by Product Type, Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年周邊血管血管造影術導管市值為 3.7821 億美元，預計到 2026 年將成長至 3.9886 億美元，預計到 2032 年將達到 6.1047 億美元，複合年成長率為 7.07%。

關鍵市場統計數據
基準年 2025 3.7821億美元
預計年份：2026年 3.9886億美元
預測年份 2032 6.1047億美元
複合年成長率 (%) 7.07%

不斷發展的臨床實踐、器械工程的突破以及採購重點的轉變正在重新定義周邊血管造影術導管市場。

周邊血管造影術導管市場環境正處於介入治療技術不斷進步和器械工程技術不斷發展的交匯點，臨床醫生日益尋求兼具精確性、柔軟性和血流動力學安全性的工具。導管設計的創新降低了周邊動脈和靜脈疾病治療的手術門檻，同時許多醫療機構正在將手術施行地點轉移到門診和日間診療中心。這些趨勢，加上臨床上對微創技術的日益重視，進一步凸顯了兼具診斷清晰度和治療多功能性的產品系列組合的策略重要性。

臨床路徑、材料創新和供應鏈韌性的關鍵轉變正在重塑血管造影術製造商的策略規劃

近年來，周邊血管造影術導管的競爭格局和臨床應用範圍發生了多項變革性變化。首先，微創影像引導介入治療的興起，推動了對小型化導管的需求，同時要求導管保持管腔完整性和扭矩響應性。其次，先進影像技術和術中引導技術的日益融合，使得導管的滲透性和附件相容性成為關注重點，從而推動了診斷和引導導管系列的設計改進。第三，近期全球範圍內的動盪使得供應鏈韌性成為一項策略重點，促使供應商多元化、策略性庫存管理以及與契約製造更緊密的合作成為必然趨勢。

分析到2025年，關稅和價值鏈重組帶來的成本壓力如何推動製造商轉向本地化、雙重採購和基於價值的籌資策略。

主要經濟體關稅的徵收和貿易政策的變化對採購、成本結構和籌資策略產生了多重影響，到2025年，累積效應將促使業內形成多種應對措施。依賴進口零件和成品的製造商正面臨利潤率壓力，因為不斷上漲的到岸成本挑戰了他們現有的定價模式。為了應對這項挑戰，許多公司正在加快本地化進程以降低風險，轉向關鍵導管組件的雙重採購策略，並重新談判供應商合約以確保價格穩定和可預測的前置作業時間。

以細分市場主導的產品和通路策略：整合設備分類、臨床需求、特定應用需求和聚合物材料優勢

清晰了解產品、最終用戶、應用和材料細分對於確定研發和商業性重點至關重要。基於產品類型的市場結構包括血管成形術導管、診斷導管、引導管、微導管和鞘套導引器器。在引導管產品系列中，Amplats、Judkins 和多用途設計分別滿足特定的解剖結構和手術需求，而 Judkins 衍生衍生又進一步細分為左旋和右旋配置，以專門用於適應外周解剖結構的冠狀動脈入路技術。每個產品系列都需要獨特的性能特徵：引導管優先考慮支撐力和扭矩控制，微導管強調在遠端和迂曲血管中的操控性，而鞘套導引器需要在止血和易於插入之間取得平衡。

美洲、歐洲、中東和非洲以及亞太地區的區域採用模式、監管差異和採購行為將如何影響製造業和商業優先事項。

區域趨勢對商業策略、監管計畫和製造地決策有顯著影響。在美洲，成熟的醫療程序應用模式與不斷成長的門診介入治療量以及對綜合診療路徑的重視並存。在美洲，複雜的報銷環境和大型醫療系統內部的集中採購模式有利於擁有強力臨床證據和一體化服務產品的供應商。在歐洲、中東和非洲，不同的法規環境和先進影像技術的普及程度差異，使得企業需要採用功能性分層、模組化的產品策略。此外，發展在地化的培訓和服務基礎設施對於推動產品應用也變得日益重要。在亞太地區，人口結構的變化、中產階級醫療保健覆蓋範圍的擴大以及對介入性心臟病學和放射學服務的大力投資，共同為高銷量、成本敏感型產品以及與國內製造商合作以應對進口和在地採購趨勢創造了有利環境。

成功的醫療設備製造商採用競爭定位和夥伴關係策略，將技術差異化、臨床證據和供應鏈優勢結合。

周邊血管造影術導管市場競爭格局複雜，由成熟的全球醫療設備公司、專業的導管技術創新者以及專注於特定臨床挑戰的敏捷型新興企業組成。大型跨國公司利用其廣泛的心血管產品組合，將器材、資本設備和支援服務打包，從而深度整合到醫院的採購流程和臨床路徑中。Start-Ups公司則專注於技術差異化，例如低剖面微導管導航技術、用於增強潤滑性和抗血栓性的混合塗層以及可降低庫存管理複雜性的模組化鞘套系統。新創公司則專注於突破性功能和行業首創材料，旨在透過有針對性的研究者主導的臨床試驗以及與主要經銷商的策略合作來證明其臨床價值。

為製造商提供切實可行的、以行動為導向的建議，以增強供應韌性，建立與臨床管道相符的產品系列，並透過證據和培訓加速臨床醫生採用。

為了將洞察轉化為可衡量的策略行動，產業領導者應優先考慮能夠平衡短期韌性和長期創新的可行事項。首先，優先考慮供應商多元化和區域製造地擴張，以保持利潤率柔軟性，同時降低關稅和物流風險。其次，透過提供模組化套件和整合SKU，根據不同機構（如門診手術中心、心臟專科中心、診斷中心或醫院）的細微需求客製化產品組合，從而簡化採購和庫存管理。第三，投資產生產品系列數據，以證實醫療設備在周邊動脈和靜脈手術的表現，尤其要重視能夠直接吸引採購委員會和支付者的真實世界註冊研究和衛生經濟學分析。

嚴謹的多學科研究途徑，結合專家訪談、臨床文獻綜合分析、監管和專利分析以及供應鏈圖譜分析，確保了研究結果的可靠性和可操作性。

本分析所依據的研究結合了結構化的初步研究（包括與領域專家的訪談）和臨床文獻、監管文件、器械註冊資料和專利概況的二次研究。初步研究包括對介入醫師、採購人員和監管顧問進行定性訪談，以了解實際應用中器械的性能預期、採購行為和臨床工作流程的限制。二次研究整合了關於周邊血管介入的同行評審研究文章、政府器械註冊文件和專業學會的程序指南，以檢驗關於臨床趨勢和材料性能的論點。

從策略層面整合了決定周邊血管血管造影術導管生態系統競爭優勢的關鍵臨床、商業性和供應鏈問題。

周邊血管造影術導管領域正處於一個轉折點：臨床對微創、高性能器械的需求不斷成長，而商業性和監管的複雜性也日益增加。導管設計和材料的技術進步使得周邊介入治療更加精準、風險更低，而採購趨勢和區域動態的變化則迫使製造商必須兼顧適應性和策略性。關稅相關的成本壓力凸顯了在地化生產和採購多元化的必要性，而門診和專科護理中心的興起正在重塑產品需求和市場推廣策略。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 周邊血管血管造影術導管市場（依產品類型分類）

  • 血管成形術導管
  • 診斷導管
  • 引導管
    • Amplatz導管
    • 朱德金斯導管
    • 多用途導管
  • 微導管
  • 鞘套導引器

9. 周邊血管血管造影術導管市場（依材料分類）

  • 聚氨酯
  • PVC
  • 矽酮

10. 依最終用戶分類的周邊血管血管造影術導管市場

  • 門診手術中心
  • 心臟中心
  • 診斷中心
  • 醫院

第11章 依應用分類的周邊血管血管造影術導管市場

  • 周邊動脈
  • 周邊靜脈

12. 周邊血管血管造影術導管市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 周邊血管血管造影術導管市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國周邊血管血管造影術導管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國周邊血管血管造影術導管市場

第16章 中國周邊血管血管造影術導管市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acandis GmbH & Co. KG
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiva Corporation
  • Cook Group Incorporated
  • Cordis Corporation
  • GE Healthcare
  • iVascular SLU
  • Koninklijke Philips NV
  • Lepu Medical Technology Co., Ltd.
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Oscor, Inc.
  • Penumbra, Inc.
  • Siemens Healthineers
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-4F7A6D4FD8BE

The Peripheral Vascular Angiography Catheter Market was valued at USD 378.21 million in 2025 and is projected to grow to USD 398.86 million in 2026, with a CAGR of 7.07%, reaching USD 610.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 378.21 million
Estimated Year [2026] USD 398.86 million
Forecast Year [2032] USD 610.47 million
CAGR (%) 7.07%

How evolving clinical practice, device engineering breakthroughs, and shifting procurement priorities are redefining the peripheral vascular angiography catheter landscape

The peripheral vascular angiography catheter landscape sits at the intersection of advancing interventional practice and evolving device engineering, where clinicians increasingly demand tools that deliver precision, flexibility, and hemodynamic safety. Innovations in catheter design have lowered procedural thresholds for treating peripheral artery and venous disease, while procedural pathways have shifted toward ambulatory and outpatient settings in many health systems. These trends, coupled with growing clinical emphasis on minimally invasive techniques, have elevated the strategic importance of product portfolios that offer both diagnostic clarity and therapeutic versatility.

Underlying this transition is a more complex supply chain and a heightened expectation for clinical evidence. Health systems and specialty centers are asking for devices that not only demonstrate technical performance in tortuous anatomy but also integrate seamlessly into existing procedural workflows. As a result, manufacturers are prioritizing improvements in deliverability, lubricity, radiopacity, and kink resistance while also investing in training programs, procedural support services, and partnerships with clinicians to accelerate adoption. This introduction frames the subsequent analysis by situating product innovation, procurement pressures, and clinical practice evolution as the primary forces shaping strategy and investment decisions in the vascular catheter arena.

Major shifts in clinical pathways, materials innovation, and supply chain resilience that are reshaping strategic planning for vascular angiography catheter manufacturers

Over recent years, several transformative shifts have altered the competitive and clinical terrain for peripheral vascular angiography catheters. First, procedural migration toward less invasive, image-guided interventions has increased demand for smaller-profile devices that maintain lumen integrity and torque response. Second, the integration of advanced imaging modalities and intraprocedural guidance has placed a premium on catheter radiopacity and accessory compatibility, prompting design refinements across diagnostic and guiding families. Third, supply chain resilience has become a strategic priority after recent global disruptions, encouraging a reassessment of supplier diversification, strategic stocking, and closer collaboration with contract manufacturers.

Simultaneously, materials science progress-particularly enhancements in polyurethane formulations and silicone coatings-has improved catheter longevity, biocompatibility, and patient comfort, while polymer selection increasingly differentiates product offerings. Clinical practice patterns have also shifted; more complex peripheral interventions now occur in ambulatory surgical centers and specialty clinics, which has led companies to develop bundled procedural solutions and simplified inventory footprints. These shifts are accompanied by a growing regulatory focus on post-market surveillance and real-world evidence, which together are nudging manufacturers to align product development with robust clinical validation and lifecycle data collection strategies.

Analyzing how tariff-driven cost pressures and supply chain realignments through 2025 have pushed manufacturers toward localization, dual-sourcing, and value-based procurement strategies

The introduction of tariffs or trade policy changes in a major economy can produce layered effects across procurement, cost structures, and sourcing strategies, and the cumulative impact through 2025 has crystallized several industry responses. Manufacturers dependent on imported components or finished devices have faced higher landed costs that challenge existing pricing models and compress margins. In response, many firms accelerated localization efforts to mitigate exposure, moved to dual-sourcing strategies for critical catheter components, and renegotiated supplier agreements to secure price stability and predictable lead times.

Procurement organizations in hospitals and specialty centers have translated increased unit costs into stricter tender evaluation and longer purchasing cycles, with an emphasis on total cost of ownership rather than unit price alone. For device makers, this has translated into more active engagement with group purchasing organizations, heightened focus on value propositions tied to procedural efficiency and complication reduction, and the exploration of financing constructs that smooth capital outlays for buyers. The cumulative regulatory and tariff-driven friction has also amplified the appeal of vertically integrated manufacturing models and regional production footprints that can insulate revenues from future trade disruptions. Collectively, these dynamics have accelerated strategic moves toward supply chain transparency, inventory optimization, and closer commercial alignment with high-volume clinical sites that can underwrite price negotiation flexibility.

Segment-driven product and channel strategies that integrate device typology, clinical setting requirements, application-specific needs, and polymer material advantages

A clear understanding of product, end-user, application, and material segmentation is essential to prioritize R&D and commercial focus. Based on product type, the landscape encompasses angioplasty catheter, diagnostic catheter, guiding catheter, microcatheter, and sheath introducer lines; within guiding catheter offerings, Amplatz, Judkins, and multipurpose designs address specific anatomic and procedural needs, and Judkins variants further bifurcate into left and right configurations tailored for coronary access approaches adapted to peripheral anatomy. Each product family demands unique performance attributes-guiding catheters prioritize backup support and torque control, microcatheters emphasize navigability in distal, tortuous vessels, and sheath introducers balance hemostasis with ease of insertion.

Considering end-user segmentation, devices are deployed across ambulatory surgical centers, cardiac specialty centers, diagnostic centers, and hospitals, and these channels differ substantially in procurement cadence, inventory tolerance, and clinical throughput. Ambulatory and specialty centers often prioritize compact, multipurpose kits that reduce turnover time and inventory complexity, whereas hospitals and diagnostic centers may require a broader range of catheter sizes and designs to accommodate higher procedural complexity. Application-focused differentiation between peripheral artery and peripheral vein interventions further influences device specification and ancillary tooling; arterial work typically demands higher support and trackability, while venous interventions emphasize flexibility and thrombus management capabilities. Material segmentation-polyurethane, PVC, and silicone-creates another axis of differentiation: polyurethane is frequently selected for a balance of strength and flexibility, PVC for cost-effective disposable implements, and silicone for improved biocompatibility and patient comfort in long-dwell or tunneled contexts. Integrating these segmentation dimensions into portfolio decisions enables companies to align product development investments with the clinical realities and procurement behaviors of their highest-value channels.

How regional adoption patterns, regulatory diversity, and procurement behavior across the Americas, Europe Middle East & Africa, and Asia-Pacific should influence manufacturing and commercial priorities

Regional dynamics exert a powerful influence on commercial strategy, regulatory planning, and manufacturing footprint decisions. In the Americas, mature procedural adoption patterns coexist with increasing outpatient intervention volume and an emphasis on bundled care pathways; here, reimbursement environment complexity and centralized purchasing at large health systems can favor suppliers with strong clinical evidence and integrated service offerings. In Europe, Middle East & Africa, heterogeneous regulatory environments and variable access to advanced imaging mean that product strategies must be more modular, with tiers of feature sets and a greater need for localized training and service infrastructure to accelerate adoption. In the Asia-Pacific region, demographic shifts, expanding middle-class access to care, and strong investment in interventional cardiology and radiology services create a fertile environment for higher-volume, cost-sensitive offerings and for partnerships with domestic manufacturers to navigate import dynamics and local procurement preferences.

Each region also presents distinct supply chain considerations: short lead times and localized stocking models in the Americas, regulatory harmonization efforts and multi-country distributor networks in Europe, Middle East & Africa, and rapid scale-up requirements paired with price sensitivity in Asia-Pacific. These regional contrasts should guide where to situate manufacturing capacity, how to structure commercial teams, and which clinical evidence packages to prioritize for regulatory submissions and payer dialogues.

Competitive positioning and partnership strategies that successful device makers use to combine technical differentiation, clinical evidence, and supply chain advantage

Competitive dynamics in the peripheral vascular angiography catheter sector are shaped by a mix of established global medtech firms, specialized catheter innovators, and nimble start-ups focused on niche clinical problems. Leading multinational companies leverage broad cardiovascular portfolios to bundle devices, capital equipment, and support services, which enables deep integration into hospital purchasing cycles and clinical pathways. Specialized firms concentrate on technical differentiation such as low-profile microcatheter navigation, hybrid coatings to enhance lubricity and thrombogenic resistance, or modular sheath systems that reduce inventory complexity. Start-ups often focus on disruptive features or first-in-class materials, aiming to demonstrate clinical value through targeted investigator-led studies and strategic partnerships with larger distributors.

Across these company types, common strategic imperatives emerge: invest in clinical evidence generation to support hospital adoption, optimize supply chains to reduce lead times and cost volatility, and build training and procedural support models that lower the operational friction for clinicians. Mergers and acquisitions continue to be a lever for scale and portfolio breadth, and strategic partnerships with contract manufacturers or regional distributors help address local market access challenges. Ultimately, companies that couple robust technical performance with clear economic value propositions and comprehensive clinician support are best placed to win long-term adoption in high-volume procedural settings.

Practical, execution-focused recommendations for manufacturers to strengthen supply resilience, tailor portfolios to clinical channels, and accelerate clinician adoption with evidence and training

To convert insights into measurable strategic moves, industry leaders should pursue a set of actionable priorities that balance near-term resilience with long-term innovation. First, prioritize supplier diversification and regional manufacturing footprints to mitigate tariff and logistics risks while preserving margin flexibility. Second, align product portfolios to the nuanced needs of ambulatory surgical centers, cardiac specialty centers, diagnostic centers, and hospitals by offering modular kits and consolidated SKUs that simplify purchasing and inventory management. Third, invest in clinical data generation that demonstrates device performance in peripheral artery and venous procedures-emphasize real-world registries and health economic analyses that speak directly to procurement committees and payers.

In parallel, refine material strategies by validating polyurethane, PVC, and silicone options across clinical scenarios to optimize performance, cost, and biocompatibility. Strengthen clinician training and procedural support through simulation, proctoring, and digital resources to accelerate adoption of newer guiding, microcatheter, and sheath introducer technologies. Finally, pursue commercial models that foreground total cost of care reductions, such as bundled pricing or outcome-tied contracts, and build partnerships with high-volume clinical sites to pilot innovative offerings before broader rollout. These recommendations, taken together, will improve resilience to policy shifts, enhance uptake in diverse clinical channels, and sharpen the value narrative for procurement decision-makers.

A rigorous blended research approach combining expert interviews, clinical literature synthesis, regulatory and patent analysis, and supply chain mapping to ensure robust, actionable insights

The research underpinning this analysis combined structured primary engagement with domain experts and targeted secondary investigation across clinical literature, regulatory filings, device registries, and patent landscapes. Primary research included qualitative interviews with interventionalists, procurement leaders, and regulatory consultants to surface real-world device performance expectations, procurement behaviors, and clinical workflow constraints. Secondary efforts synthesized peer-reviewed studies on peripheral interventions, governmental device registration documents, and procedural guidance from professional societies to validate clinical trends and material performance claims.

Supplementing these sources, supply chain mapping and vendor capability assessments were conducted to identify concentration risks, lead-time sensitivities, and redundancies in critical component sourcing. Competitive positioning analysis drew on publicly available product documentation, patent filings, and clinical trial registries to evaluate differentiation and pipeline activity. Throughout, findings were triangulated to ensure consistency between clinical practice patterns, procurement signals, and product feature sets, producing a defensible and actionable body of insights for strategic decision-making.

Strategic synthesis of clinical, commercial, and supply chain imperatives that will determine competitive winners in the peripheral vascular angiography catheter ecosystem

The peripheral vascular angiography catheter sector is at an inflection point where clinical demand for minimally invasive, high-performance devices meets heightened commercial and regulatory complexity. Technological advances in catheter design and materials are enabling more precise, lower-risk peripheral interventions, while shifting procurement and regional dynamics require manufacturers to be both adaptable and strategic. Tariff-related cost pressures have underscored the need for localized manufacturing and diversified sourcing, and the rise of ambulatory and specialty care settings has reshaped product requirements and go-to-market approaches.

For decision-makers, the path forward is clear: align product development with the differentiated needs of specific clinical channels and applications, invest in robust clinical evidence and clinician support programs, and shore up supply chain resilience to protect margins and ensure continuity of supply. Companies that successfully integrate these elements will be better positioned to win preference among clinicians and procurement leaders and to sustain adoption as procedural volumes continue to migrate to less invasive care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Angiography Catheter Market, by Product Type

  • 8.1. Angioplasty Catheter
  • 8.2. Diagnostic Catheter
  • 8.3. Guiding Catheter
    • 8.3.1. Amplatz Catheter
    • 8.3.2. Judkins Catheter
    • 8.3.3. Multipurpose Catheter
  • 8.4. Microcatheter
  • 8.5. Sheath Introducer

9. Peripheral Vascular Angiography Catheter Market, by Material

  • 9.1. Polyurethane
  • 9.2. PVC
  • 9.3. Silicone

10. Peripheral Vascular Angiography Catheter Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Cardiac Specialty Center
  • 10.3. Diagnostic Center
  • 10.4. Hospitals

11. Peripheral Vascular Angiography Catheter Market, by Application

  • 11.1. Peripheral Artery
  • 11.2. Peripheral Vein

12. Peripheral Vascular Angiography Catheter Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Peripheral Vascular Angiography Catheter Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Peripheral Vascular Angiography Catheter Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Peripheral Vascular Angiography Catheter Market

16. China Peripheral Vascular Angiography Catheter Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acandis GmbH & Co. KG
  • 17.6. AngioDynamics, Inc.
  • 17.7. Asahi Intecc Co., Ltd.
  • 17.8. B. Braun Melsungen AG
  • 17.9. Becton, Dickinson and Company
  • 17.10. Biotronik SE & Co. KG
  • 17.11. Boston Scientific Corporation
  • 17.12. Cardiva Corporation
  • 17.13. Cook Group Incorporated
  • 17.14. Cordis Corporation
  • 17.15. GE Healthcare
  • 17.16. iVascular S.L.U.
  • 17.17. Koninklijke Philips N.V.
  • 17.18. Lepu Medical Technology Co., Ltd.
  • 17.19. Medikit Co., Ltd.
  • 17.20. Medtronic plc
  • 17.21. Merit Medical Systems, Inc.
  • 17.22. MicroPort Scientific Corporation
  • 17.23. Nipro Corporation
  • 17.24. Oscor, Inc.
  • 17.25. Penumbra, Inc.
  • 17.26. Siemens Healthineers
  • 17.27. Teleflex Incorporated
  • 17.28. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY ANGIOPLASTY CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY ANGIOPLASTY CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY ANGIOPLASTY CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMPLATZ CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMPLATZ CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMPLATZ CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY JUDKINS CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY JUDKINS CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY JUDKINS CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MULTIPURPOSE CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MULTIPURPOSE CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MULTIPURPOSE CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MICROCATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MICROCATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MICROCATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SHEATH INTRODUCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SHEATH INTRODUCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SHEATH INTRODUCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY CARDIAC SPECIALTY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY CARDIAC SPECIALTY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY CARDIAC SPECIALTY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL VEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL VEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL VEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 117. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 135. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 141. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)